[1] Janssens S,Beyaert R. Role of Toll-like receptors in pathogen recognition[J]. Clin Microbiol Rev,2003,16(4):637-646.
[2] Akira S,Takeda K,Kaisho T. Toll-like receptors:critical proteins linking innate and acquired immunity[J]. Nat Immunol,2001,2(8):675-680.
[3] Schmausser B,Andrulis M,Endrich S,et al. Toll-like receptors TLR4,TLR5 and TLR9 on gastric carcinoma cells: an implication for interaction with Helicobacter pylori[J]. Int J Med Microbiol,2005,295(3):179-185.
[4] Huang B,Zhao J,Shen S,et al. Listeria monocytogenes promotes tumor growth via tumor cell toll-like receptor 2 signaling[J]. Cancer Res,2007,67(9):4346-4352.
[5] Van Gent M,Braem SG,de Jong A,et al. Epstein-Barr virus large tegument protein BPLF1 contributes to innate immune evasion through interference with toll-like receptor signaling[J]. PLoS Pathog,2014,10(2):1003960.
[6] Fukayama M,Chong JM,Kaizaki Y. Epstein-Barr virus and gastric carcinoma[J]. Gastric Cancer,1998,1(2):104-114.
[7] 梁 华,罗 兵,王 云,等. 胃癌和相应癌旁组织中EB病毒感染的检测[J]. 青岛大学医学院学报,2003,39 (4):228-232.
[8] Rad R,Ballhorn W,Voland P,et al. Extracellular and intracellular pattern recognition receptors cooperate in the recognition of Helicobacter pylori[J]. Gastroenterology,2009, 136(7):2247-2257.
[9] El-Omar EM,Ng MT,Hold GL. Polymorphisms in Toll-like receptor genes and risk of cancer[J]. Oncogene,2008,27(2): 244-252.
[10] Tahara T,Arisawa T,Wang F,et al. Toll-like receptor 2 -196 to 174del polymorphism influences the susceptibility of Japanese people to gastric cancer[J]. Cancer Sci,2007, 98(11):1790-1794.
[11] de Oliveira JG,Silva AE. Polymorphisms of the TLR2 and TLR4 genes are associated with risk of gastric cancer in a Brazilian population[J]. World J Gastroenterol,2012,18(11): 1235-1242.
[12] Hunt R,Sauna ZE,Ambudkar SV,et al. Silent (synonymous) SNPs:should we care about them?[J]. Methods Mol Biol, 2009,578:23-39.
[13] 曾红梅,潘凯枫,张 阳,等. Toll样受体2及Toll样受体9基因多态性与胃癌易感性的关系[J]. 中华预防医学杂志,2011,45(7):588-592.
[14] Kim MK,Park SW,Kim SK,et al. Association of Toll-like receptor 2 polymorphisms with papillary thyroid cancer and clinicopathologic features in a Korean population[J]. J Korean Med Sci,2012,27(11):1333-1338.
[15] Junjie X,Songyao J,Minmin S,et al. The association between Toll-like receptor 2 single-nucleotide polymorphisms and hepatocellular carcinoma susceptibility[J]. BMC Cancer, 2012,12(1):57.
[16] Petrara MR,Freguja R,Gianesin K,et al. Epstein-Barr virus-driven lymphomagenesis in the context of human immunodeficiency virus type 1 infection[J]. Front Microbiol, 2013,4:311.
[17] Moumad K,Lascorz J,Bevier M,et al. Genetic polymor-phisms in host innate immune sensor genes and the risk of nasopharyngeal carcinoma in North Africa[J]. G3 (Bethesda), 2013,3(6):971-977.
[18] Valente RM,Ehlers E,Xu D,et al. Toll-like receptor 7 stimulates the expression of Epstein-Barr virus latent membrane protein 1[J]. PLoS One,2012,7(8):43317.
[19] He JF,Jia WH,Fan Q,et al. Genetic polymorphisms of TLR3 are associated with nasopharyngeal carcinoma risk in Cantonese population[J]. BMC Cancer,2007,7:194.
[20] Yang CA,Scheibenbogen C,Bauer S,et al. A frequent Toll-like receptor 1 gene polymorphism affects NK- and T-cell IFN-gamma production and is associated with Helicobacter pylori-induced gastric disease[J]. Helicobacter,2013,18(1):13-21. |